In Latest PGx Pact with Population Genetics, Quintiles Hopes to Save Pharma Money and Time

The deal gives Quintiles access to PGT’s genomic data-analysis technology, and is in line with Quintiles' ongoing efforts to expand its pharmacogenomics research capabilities.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.